Encouraging results of a clinical trial of NICHI GLOW, one of the products under NICHI GLUCAN brand in children with Autism Spectrum Disorder has been published BMJ Neurology Open (http://dx.doi.org/10.1136/bmjno-2021-000203).
Taking this opportunity, GN Corporation will participate in the “Autism Sunday” to be held on February 13, 2022 from 1:30 pm, JST in which parents of children who participated in the study will join and a panel discussion involving scientists, clinicians, NGOs, social workers from United Kingdom, USA, India, Mauritius, Japan and Srilanka will be conducted.
This meeting was started in London in 2000 and observed every year in the Second Sunday of February (https://en.wikipedia.org/wiki/Autism_Sunday).
For more information on “Autism Sunday 2022”, please click here.
